Multiple Sclerosis (MS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Multiple Sclerosis (MS) Market Outlook Thelansis’s “Multiple Sclerosis (MS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Multiple Sclerosis (MS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Multiple Sclerosis (MS) Overview Multiple Sclerosis (MS) is an autoimmune disease affecting the central nervous system (CNS), characterized by chronic inflammation, demyelination, gliosis, and neuronal loss. Lesions in the CNS can manifest at different times and locations, leading to the description of MS lesions as being “disseminated in time and space.” The clinical course of MS varies widely, ranging from a s...